<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genes Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Genes Dis</journal-id>
<journal-title-group>
<journal-title>Genes &amp; Diseases</journal-title>
</journal-title-group>
<issn pub-type="ppub">2352-4820</issn>
<issn pub-type="epub">2352-3042</issn>
<publisher>
<publisher-name>Chongqing Medical University</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30258928</article-id>
<article-id pub-id-type="pmc">6147084</article-id>
<article-id pub-id-type="publisher-id">S2352-3042(18)30004-7</article-id>
<article-id pub-id-type="doi">10.1016/j.gendis.2018.01.002</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>DNA methylation in human diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Zelin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yun</given-names>
</name>
<email>yliu39@fudan.edu.cn</email>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
</contrib-group>
<aff id="aff1">The Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author. Fax: +86 021 64033738. <email>yliu39@fudan.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>31</day>
<month>1</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="collection">
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>5</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>8</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>1</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 Chongqing Medical University. Production and hosting by Elsevier B.V.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Chongqing Medical University</copyright-holder>
<license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0010">
<p>Even though the importance of epigenetics was first recognized in light of its role in tissue development, an increasing amount of evidence has shown that it also plays an important role in the development and progression of many common diseases. We discuss some recent findings on one representative epigenetic modification, DNA methylation, in some common diseases. While many new risk factors have been identified through the population-based epigenetic epidemiologic studies on the role of epigenetics in common diseases, this relatively new field still faces many unique challenges. Here, we describe those promises and unique challenges of epigenetic epidemiological studies and propose some potential solutions.</p>
</abstract>
<kwd-group id="kwrds0010">
<title>Keywords</title>
<kwd>DNA Methylation</kwd>
<kwd>Epigenetic epidemiologic studies</kwd>
<kwd>Epigenetics</kwd>
<kwd>EWAS</kwd>
<kwd>Human diseases</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p id="p0010">The term “epigenetics” was coined by Conrad Hal Waddington, a British developmental biologist in 1942, to describe the “whole complex of developmental processes” linking genotype and phenotype.<xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib2">2</xref> Since then, this concept has changed several times,<xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref> and recent studies on epigenetics at the molecular level mainly cover changes in DNA methylation, histone modifications, non-coding RNAs, and higher-order chromatin structure. Even though the role of epigenetics was first recognized in development, an increasing amount of evidence has shown that it is also related to the development and progression of many common diseases. Here, we first review the role of epigenetics, and mainly DNA methylation, in common human diseases.</p>
<sec id="sec1">
<title>Introduction to DNA methylation</title>
<p id="p0015">DNA methylation is one of the earliest epigenetic modifications found in humans.<xref ref-type="bibr" rid="bib5"><sup>5</sup></xref> It is a type of post-replication modification that often occurs in cytosines of the CpG dinucleotide sequence with the help of DNA methyltransferases (DNMTs),<xref ref-type="bibr" rid="bib6"><sup>6</sup></xref> which transfer a methyl group from S-adenyl methionine to the fifth carbon of a cytosine residue to form 5-methylcytosine (5mC). The process of demethylation is more complex and can be passive or active. Ten-eleven translocation (TET) enzymes oxidize 5mCs<xref ref-type="bibr" rid="bib7">7</xref>, <xref ref-type="bibr" rid="bib8">8</xref> and promote locus-specific removal of DNA methylation.<xref ref-type="bibr" rid="bib9"><sup>9</sup></xref> Specifically, in the presence of water, oxygen, and α-ketoglutarate, 5mC becomes 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) through stepwise oxidation, yielding carbon dioxide and succinate.<xref ref-type="bibr" rid="bib9"><sup>9</sup></xref> Then both 5fC and 5caC can be replaced by an unmodified cytosine through thymine DNA glycosylase-mediated base-excision repair.<xref ref-type="bibr" rid="bib8">8</xref>, <xref ref-type="bibr" rid="bib10">10</xref></p>
</sec>
<sec id="sec2">
<title>Genomic imprinting</title>
<p id="p0020">The role of DNA methylation in human diseases was first explored in the context of genomic imprinting. Genetic imprinting is an epigenetic phenomenon in which the maternal and paternal alleles are expressed in a parent-of-origin-specific manner. Genomic imprinting is stable and heritable during mitosis.<xref ref-type="bibr" rid="bib11"><sup>11</sup></xref> A relatively well-studied imprinting locus in humans is the <italic>insulin-like growth factor 2 (IGF2)/H19</italic> region, located on chromosome 11p15.5, in which DNA methylation on the imprinting control region (ICR) regulates the binding of zinc-finger CCCTC-binding factor (CTCF) and subsequent gene expression.<xref ref-type="bibr" rid="bib12"><sup>12</sup></xref> Loss of imprinting (LOI) causes many disorders such as Beckwith–Wiedemann Syndrome and cancer (which will be discussed later). Similarly, LOI of paternally-inherited chromosome 15q11.2-q13 is observed in Prader–Willi syndrome,<xref ref-type="bibr" rid="bib13"><sup>13</sup></xref> and LOI of this region is also implicated in Angelman syndrome.<xref ref-type="bibr" rid="bib14"><sup>14</sup></xref></p>
</sec>
<sec id="sec3">
<title>DNA methylation and cancer</title>
<p id="p0025">Aberrant DNA methylation of imprinted loci has been widely observed in many cancer types, such as colon, breast, liver, bladder, Wilms, ovarian, esophageal, prostate, and bone cancers. In addition, recent studies on the applications of omics technologies have shown that there are many differential DNA methylation related to cancers, such as hepatocellular carcinoma, glioblastoma, breast cancer, squamous cell lung cancer, thyroid carcinoma, and leukemia.<xref ref-type="bibr" rid="bib15">15</xref>, <xref ref-type="bibr" rid="bib16">16</xref>, <xref ref-type="bibr" rid="bib17">17</xref>, <xref ref-type="bibr" rid="bib18">18</xref>, <xref ref-type="bibr" rid="bib19">19</xref>, <xref ref-type="bibr" rid="bib20">20</xref>, <xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib23">23</xref>, <xref ref-type="bibr" rid="bib24">24</xref>, <xref ref-type="bibr" rid="bib25">25</xref> Furthermore, DNMT mutations, different expression levels of DNMTs or as well as dysregulation of TETs are frequently observed in cancer, all of which suggest a strong connection between DNA methylation and cancer. There are many good reviews discussing the role of epigenetic changes in cancer (see Feinberg et al Nat. Rev. Genet. 2016<xref ref-type="bibr" rid="bib26"><sup>26</sup></xref>; Timp et al Nat. Rev. Cancer 2013<xref ref-type="bibr" rid="bib27"><sup>27</sup></xref>). Even though epigenetic alterations have not been recognized as a “Hallmark” of cancer yet,<xref ref-type="bibr" rid="bib28">28</xref>, <xref ref-type="bibr" rid="bib29">29</xref> recent works point out that epigenetic changes in cancer over large chromatin regions can lead to epigenetic instability and the alteration of gene expression. While epigenetic changes can regulate stem cell reprogramming and cellular plasticity in normal development, disrupted epigenetic changes in cancer may eventually lead to tumor cell heterogeneity. Moreover, difference in epigenetic reprogramming has been observed between primary tumor and distant metastases in the same individual,<xref ref-type="bibr" rid="bib30"><sup>30</sup></xref> while, in contrast, no driver mutations were identified among the metastases.<xref ref-type="bibr" rid="bib31"><sup>31</sup></xref> All these suggest that epigenetic dysregulation plays an important role in tumor development and metastasis, and also indicates its potential application in the diagnosis,<xref ref-type="bibr" rid="bib32">32</xref>, <xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref> prognosis<xref ref-type="bibr" rid="bib35"><sup>35</sup></xref> and the treatment of cancer.<xref ref-type="bibr" rid="bib36">36</xref>, <xref ref-type="bibr" rid="bib37">37</xref></p>
</sec>
<sec id="sec4">
<title>DNA methylation and common diseases</title>
<p id="p0030">In addition to genomic imprinting and cancer, the important role of DNA methylation in common human diseases has recently been revealed. In the subsequent sections, we discuss some recent findings on DNA methylation in these common human diseases using autoimmune diseases, metabolic disorders, psychological disorders, and aging as examples.</p>
<sec id="sec4.1">
<title>DNA methylation in autoimmune diseases</title>
<p id="p0035">Autoimmune diseases are caused by low activity or over activity of the immune system. Immune cells are the primary targets in disease and are easily accessible from the blood, making them a relatively good model for studying the link between DNA methylation and phenotypes. Moreover, the low concordance rates in monozygotic twins for many of them such as rheumatoid arthritis (RA, 12.3–21%),<xref ref-type="bibr" rid="bib38">38</xref>, <xref ref-type="bibr" rid="bib39">39</xref> systemic lupus erythematosus (SLE, 11.1–24.4%),<xref ref-type="bibr" rid="bib40">40</xref>, <xref ref-type="bibr" rid="bib41">41</xref> and multiple sclerosis (MS, 16.7%)<xref ref-type="bibr" rid="bib42"><sup>42</sup></xref> indicates that the environment or epigenetics may play important roles in disease etiology.</p>
<p id="p0040">RA is a chronic autoimmune inflammatory disease with an estimated global prevalence of 0.3–1.0%.<xref ref-type="bibr" rid="bib43"><sup>43</sup></xref> It can cause symmetrical polyarthritis in small and large joints.<xref ref-type="bibr" rid="bib44"><sup>44</sup></xref> Genome-wide DNA methylation analysis of peripheral blood mononuclear cells showed that altered DNA methylation of human leukocyte antigen (HLA) class II can mediate the genetic risk of developing RA.<xref ref-type="bibr" rid="bib45"><sup>45</sup></xref> In adjuvant arthritic rats (animal models of RA), a high methylation level of the patched 1 (PTCH1) gene and decreased expression of PTCH1 protein activated the Hedgehog signaling pathway, leading to the increased secretion of interleukin 6 (IL-6) and tumor necrosis factor alpha.<xref ref-type="bibr" rid="bib46"><sup>46</sup></xref> In addition, the level of DNA methylation at diagnosis is associated with the response to disease-modifying anti-rheumatic drug treatment in early RA,<xref ref-type="bibr" rid="bib47"><sup>47</sup></xref> indicating that these sites may potentially be involved in the pathway associated with RA development. Moreover, our recent data showed that DNA methylation mediates the interaction between genotype and smoking in the development of RA, indicating that it can potentially integrate both internal genetic and external environmental risk factors.<xref ref-type="bibr" rid="bib48"><sup>48</sup></xref> This highlights the potential central role of DNA methylation in the development of RA.</p>
<p id="p0045">SLE is an autoimmune disease in which the immune system mistakenly attacks healthy tissue in many parts of the body. A genome-wide assessment of DNA methylation identified differential DNA methylation in SLE patients in genes involved in autoantibody production.<xref ref-type="bibr" rid="bib49"><sup>49</sup></xref> In peripheral blood of SLE patients, low levels of DNA methylation was observed in the promoter of IL-6 gene.<xref ref-type="bibr" rid="bib50"><sup>50</sup></xref> Furthermore, the methylation status of naïve CD4+ T cells is related to different cutaneous manifestations and an investigation with neutrophils from SLE patients found DNA hypomethylation at the specific insulin receptor substrate for long interspersed nuclear element-1 (LINE-1).<xref ref-type="bibr" rid="bib51"><sup>51</sup></xref></p>
<p id="p0050">MS is the most common cause of neurological disability in young adults with a lifetime risk of 1 in 400.<xref ref-type="bibr" rid="bib52"><sup>52</sup></xref> It is a chronic inflammatory and neurodegenerative disease that is self-immune mediated.<xref ref-type="bibr" rid="bib52"><sup>52</sup></xref> Although the etiology of MS remains largely unknown, genetic and environmental factors are thought to play a role. Changes in DNA methylation have been observed in multiple immune cell types in MS patients including CD4+ T cells, CD8+ T cells, and CD44+ encephalitogenic T cells,<xref ref-type="bibr" rid="bib53"><sup>53</sup></xref> and it is also altered in the hippocampi of patients with MS after demyelination.<xref ref-type="bibr" rid="bib54"><sup>54</sup></xref> Additionally, smoking, a risk factor for MS, can alter the DNA methylation level in MS patients through the interaction of major genetic risk factors (female and HLA risk haplotypes).<xref ref-type="bibr" rid="bib55"><sup>55</sup></xref> This indicates that, similar to RA,<xref ref-type="bibr" rid="bib48"><sup>48</sup></xref> DNA methylation can be influenced by gene and environment and may play a role in the pathogenesis of MS.</p>
</sec>
<sec id="sec4.2">
<title>DNA methylation in metabolic disorders</title>
<p id="p0055">Hyperglycemia (which can lead to type I and type II diabetes), hyperlipidemia (such as obesity-related conditions), and many diseases associated with these two phenomena, such as cardiovascular diseases, are currently a huge risk of death. Understanding the epigenetic mechanisms leading towards these conditions will have huge public health benefits. The symptoms of diabetes include increased thirst, frequent urination, and unexplained weight loss.<xref ref-type="bibr" rid="bib56"><sup>56</sup></xref> These are consequences of insulin resistance or insulin insensitivity, which lead to hyperglycemia. Type 2 diabetes mellitus (T2BM) is a complex disorder caused by a series of factors including genetics, epigenetics, and environmental factors. A comparison of the methylation level of islets in patients with T2BM with those from normal donors showed that a series of sites had different DNA methylation levels which led to differential gene expression.<xref ref-type="bibr" rid="bib57"><sup>57</sup></xref> That included the decreased methylation of cyclin-dependent kinase inhibitor 1A and phosphodiesterase 7B promoters, which demonstrates impaired glucose-stimulated insulin secretion both <italic>in vitro</italic> and in humans.<xref ref-type="bibr" rid="bib57"><sup>57</sup></xref> Shortened leukocyte telomere length was also proposed to affect the DNA methylation level of LINE-1, which may increase the risk of T2BM in Chinese patients.<xref ref-type="bibr" rid="bib58"><sup>58</sup></xref> Methylation of thioredoxin-interacting protein is sensitive to glucose concentrations, and its hypomethylation has been observed in patients with hyperglycemia.<xref ref-type="bibr" rid="bib59"><sup>59</sup></xref> Obesity is another common disease in which the environment plays an important role. Genome-wide analysis showed that increased DNA methylation of hypoxia-inducible factor 3 alpha in both blood cells and adipose tissue is associated with an increased body mass index (BMI).<xref ref-type="bibr" rid="bib60"><sup>60</sup></xref> Offspring DNA methylation of Aryl-Hydrocarbon Receptor Repressor (AHRR) correlates with maternal BMI, gestational age, and birth weight.<xref ref-type="bibr" rid="bib61"><sup>61</sup></xref> In addition, the DNA methylation level of two proteins important for fat metabolism, leptin and adiponectin, is positively correlated with BMI and waist girth,<xref ref-type="bibr" rid="bib62"><sup>62</sup></xref> whereas the methylation level of the leptin gene in blood cells is negatively correlated with BMI.<xref ref-type="bibr" rid="bib62"><sup>62</sup></xref> It has also been proposed that low-density lipoprotein cholesterol (LDL-C) may be a key regulator of the DNA methylation profile of leptin and adiponectin in adipose tissues. Changes in genotype-dependent DNA methylation have been observed in the promoter of the actin-related protein 2/3 complex subunit 3, a gene related to lipogenesis and lipid accumulation, and this was proposed to be a risk factor for obesity-related disorders.<xref ref-type="bibr" rid="bib63"><sup>63</sup></xref> Moreover, studies have shown the correlation between DNA methylation and many metabolic traits such as high-density levels of lipoprotein cholesterol,<xref ref-type="bibr" rid="bib64">64</xref>, <xref ref-type="bibr" rid="bib65">65</xref>, <xref ref-type="bibr" rid="bib66">66</xref> LDL,<xref ref-type="bibr" rid="bib67"><sup>67</sup></xref> and triglycerides.<xref ref-type="bibr" rid="bib67"><sup>67</sup></xref></p>
</sec>
<sec id="sec4.3">
<title>DNA methylation in neurological disorders</title>
<p id="p0060">Neurological disorders are other types of diseases in which DNA methylation is believed to play an important role in development. This correlation was suggested when frequent mutations in the Methyl-CpG-binding protein 2 (MeCP2) gene was observed in patients with autism spectrum disorder (ASD)<xref ref-type="bibr" rid="bib68"><sup>68</sup></xref> and Rett Syndrome,<xref ref-type="bibr" rid="bib69">69</xref>, <xref ref-type="bibr" rid="bib70">70</xref> a neurodevelopmental disorder affecting about 1 in 10,000 female babies. MeCP2 binds to DNA sequences with methylated CpG and methylated CH (H refers to A, C, or T), which is key to regulating neuronal gene expression <italic>in vivo</italic>.<xref ref-type="bibr" rid="bib71">71</xref>, <xref ref-type="bibr" rid="bib72">72</xref> It has been proposed that changes in the DNA methylation profile lead to the differential expression of genes related to synaptic activity,<xref ref-type="bibr" rid="bib73"><sup>73</sup></xref> and that the different binding affinity of MeCP2 protein to methylated DNA can regulate the expression level of genes related to the pathophysiology of autism<xref ref-type="bibr" rid="bib74"><sup>74</sup></xref> and Rett Syndrome such as brain derived neurotrophic factor.<xref ref-type="bibr" rid="bib75"><sup>75</sup></xref> In addition to genetic mutations related to the epigenetic regulation of gene expression, studies have shown that some environmental factors (such as exposure to garden pesticide) can affect DNA methylation levels in placental tissue, which put children at high risk for ASD.<xref ref-type="bibr" rid="bib76"><sup>76</sup></xref> A genome-wide study measuring neuron-specific methylation situations in ASD identified some differentially methylated regions between the ASD and control groups.<xref ref-type="bibr" rid="bib77"><sup>77</sup></xref> Combined genetic and epigenetic measurements also revealed both known and new pathways involved in ASD that had not previously been made known by genetic findings alone.<xref ref-type="bibr" rid="bib78"><sup>78</sup></xref> The role of DNA methylation in other mental disorders has also been explored. For example, the methylation level of catechol-O-methyl transferase in peripheral blood was lower in patients with schizophrenia (SZ) than in healthy controls in a Malaysian study,<xref ref-type="bibr" rid="bib79"><sup>79</sup></xref> which seemed to be affected by the severity of the clinical symptoms as well as the pharmacological treatment.<xref ref-type="bibr" rid="bib79"><sup>79</sup></xref> Moreover, crosstalk between different epigenetic signals including DNA methylation, histone modifications, and micro RNAs was also suggested in the development of SZ.<xref ref-type="bibr" rid="bib80">80</xref>, <xref ref-type="bibr" rid="bib81">81</xref> In addition, some genome-wide studies found that differentially methylated CpGs are strongly related to the development of Parkinson's disease (PD), either from the cerebral cortex,<xref ref-type="bibr" rid="bib82"><sup>82</sup></xref> or from blood and saliva.<xref ref-type="bibr" rid="bib83"><sup>83</sup></xref> The DNA was significantly hypomethylated in the promoter regions of α-synuclein and parkin in early-onset PD patients.<xref ref-type="bibr" rid="bib84"><sup>84</sup></xref> Although relatively successful, most of these studies were performed on surrogate tissues, such as blood, or in a relatively small sample size, due to difficulties in obtaining enough samples from neuropathological examinations (especially brain tissues), and large brain biobanks are needed for validation and replication of these findings in the neural bio specimens.</p>
</sec>
<sec id="sec4.4">
<title>DNA methylation and aging</title>
<p id="p0065">Aging is a process of becoming old with many physical and psychological consequences. Even though it is a natural process, it can be biologically classified as a disease.<xref ref-type="bibr" rid="bib85"><sup>85</sup></xref> Many years ago, age-related DNA methylation changes were observed in several species such as salmon,<xref ref-type="bibr" rid="bib86"><sup>86</sup></xref> rats,<xref ref-type="bibr" rid="bib87"><sup>87</sup></xref> and mice.<xref ref-type="bibr" rid="bib88"><sup>88</sup></xref> In recent years, work from Steve Horvath's group showed that measuring DNA methylation levels at 353 CpG sites can be a good estimator of the biological age of a tissue, cell type, organ, or even individuals.<xref ref-type="bibr" rid="bib89">89</xref>, <xref ref-type="bibr" rid="bib90">90</xref> This type of DNA clock is known as an epigenetic or DNA methylation clock, and has proved to be a good age predictor in many heterogeneous tissues such as whole blood, PMBCs, cerebellar samples, occipital cortex, buccal epithelium, colon, adipose, liver, lung, saliva, and uterine cervix, as well as in individual cell types such as CD4 T cells and CD14 monocytes (myeloid lineage).<xref ref-type="bibr" rid="bib89">89</xref>, <xref ref-type="bibr" rid="bib90">90</xref> Interestingly, in contrast with normal people, accelerated DNA methylation age is found in individuals with diseases such as PD,<xref ref-type="bibr" rid="bib91"><sup>91</sup></xref> Huntington's disease,<xref ref-type="bibr" rid="bib92"><sup>92</sup></xref> and Alzheimer's disease,<xref ref-type="bibr" rid="bib93"><sup>93</sup></xref> as well as some viral infections.<xref ref-type="bibr" rid="bib94"><sup>94</sup></xref> All these findings suggest that DNA methylation may not only be suitably viewed as a biomarker of aging, but may also be related the pathological process of aging itself.</p>
</sec>
</sec>
<sec id="sec5">
<title>Challenges in epigenetic epidemiological studies focused on DNA methylation</title>
<p id="p0070">With the abundance of emerging evidence indicating the important role of DNA methylation in common diseases, researchers have attempted to use DNA methylation as a biomarker to identify epigenetic changes that are associated with disease status. It is believed that this population-based epidemiologic approach for studying the role of epigenetics in common diseases can be used to identify new risk factors that might be missed by conventional genetic epidemiologic approaches such as the genome-wide association study (GWAS); this epigenetic epidemiologic approach is also known as the epigenome-wide association study (EWAS). Even though epigenetic epidemiological studies hold much promise<xref ref-type="bibr" rid="bib95"><sup>95</sup></xref> and are conceptually relatively simple, there are in fact, many unique challenges to this approach. Here, we describe some of them and propose some potential solutions.</p>
<p id="p0075">Since DNA methylation profiles differ for each tissue, it is understandable that it is more relevant to perform experiments on primary disease-affected tissues in EWAS. Even though this may not be difficult for autoimmune diseases, as immune cells are easily accessible from blood, it can be quite challenging for many other diseases such as neurological disorders in which human biopsies of target organs from healthy controls are difficult to obtain, especially when a large number of samples are needed for epidemiology studies. Many studies have proposed to use blood as a surrogate tissue under the assumption that some epigenetic changes in target tissue can also be observed in the blood; however, the suitability of using a surrogate tissue is still a subject of debate.<xref ref-type="bibr" rid="bib96">96</xref>, <xref ref-type="bibr" rid="bib97">97</xref> Although disease-associated epigenetic changes observed in surrogate tissue such as blood may be useful as a biomarker in certain clinical settings, to prove the biological importance of these associations, it is necessary to validate these changes in disease-related tissue. This also highlights the importance of establishing biobanks that not only collect blood, as is done for genetic epidemiology studies, but also collect tissues directly involved in disease development.</p>
<p id="p0080">The second challenge in performing many EWAS studies is that the starting materials used to generate DNA methylation profiles are usually derived from heterogeneous cell populations. For example, DNA samples readily available from most genetic epidemiology studies are usually from whole blood, which includes many different cell types with distinct biological functions. Moreover, the proportion of each cell type is variable among individuals and can be affected by disease status, making it a potential confounding factor in association analyses. Many statistical approaches have been proposed to perform cell-type deconvolution and identify epigenetic changes that are not the result of a shift in cell type. Some reference-based approaches have used unique DNA methylation signatures from each cell type to estimate their proportions and then performed subsequent adjustments with these estimate.<xref ref-type="bibr" rid="bib45"><sup>45</sup></xref> Obviously, this type of approach depends on the availability of the reference DNA methylation profiles of each cell type, and to date, has been applied in PBMC,<xref ref-type="bibr" rid="bib45">45</xref>, <xref ref-type="bibr" rid="bib98">98</xref>, <xref ref-type="bibr" rid="bib99">99</xref> cord blood,<xref ref-type="bibr" rid="bib100">100</xref>, <xref ref-type="bibr" rid="bib101">101</xref> and the prefrontal cortex.<xref ref-type="bibr" rid="bib102"><sup>102</sup></xref> Additionally, this approach assumes that the DNA methylation signature used to estimate cellular proportions is not affected by the disease status. Because of these limitations, several reference-free approaches such as EWASher,<xref ref-type="bibr" rid="bib103"><sup>103</sup></xref> ReFACTOR,<xref ref-type="bibr" rid="bib104"><sup>104</sup></xref> RefFreeEWAS,<xref ref-type="bibr" rid="bib105"><sup>105</sup></xref> RUVm,<xref ref-type="bibr" rid="bib106"><sup>106</sup></xref> and SVA<xref ref-type="bibr" rid="bib107">107</xref>, <xref ref-type="bibr" rid="bib108">108</xref> have been proposed. However, the performance of these reference-free approaches strongly depends on the validity of model assumptions.<xref ref-type="bibr" rid="bib109"><sup>109</sup></xref></p>
<p id="p0085">The third challenge is that because DNA methylation can be influenced by both genetic factors and environmental changes, its role in disease etiology can be rather complicated (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). This is straightforward if disease phenotype is only affected by genotype (as in Mendelian disorders), or the environment (as in infectious diseases). However, in the development of common diseases, DNA methylation can be a mediator, modifier, or even consequence of the disease. For example, as a mediator, DNA methylation can be an intermediary in the disease etiology of genetic<xref ref-type="bibr" rid="bib45">45</xref>, <xref ref-type="bibr" rid="bib98">98</xref> or environmental risk factors.<xref ref-type="bibr" rid="bib110">110</xref>, <xref ref-type="bibr" rid="bib111">111</xref> In some cases, DNA methylation can even act as an integrator of both internal genetic and external environmental risk factors in disease development, as demonstrated in RA<xref ref-type="bibr" rid="bib48"><sup>48</sup></xref> and MS<xref ref-type="bibr" rid="bib55"><sup>55</sup></xref>. As a modifier, DNA methylation can also influence the relationship between genotype (or environment) and disease phenotype. Even though this relationship has not been explored so far, the gene-environment interaction (GxE) has been widely observed in the development of many diseases, and it is not surprising that DNA methylation plays a role in this process. Additionally, because DNA methylation is relatively dynamic and can be influenced by many factors (e.g., age, gender, race, life style, living conditions), they are all potential confounders that should be considered in the epidemiology study. All these make it difficult to build one simple model to study the potential roles of DNA methylation, and so careful experimental design is vital to any successful epigenetic epidemiology study.<fig id="fig1"><label>Figure 1</label><caption><p>The relationship between genetics, epigenetics and environmental exposures on disease phenotype.</p></caption><graphic xlink:href="gr1"></graphic></fig></p>
<p id="p0090">Another challenge for epigenetic epidemiology studies is to establish the causal role of epigenetic changes. While we are interested in the way changes in DNA methylation play a role in disease etiology, DNA methylation can also be affected by the disease itself, and this needs to be distinguished from the biology of the disease. Unlike GWAS, this is another unique challenge in performing EWAS. In addition to using molecular biochemistry experiments (e.g., <italic>in vitro</italic> luciferase reporter assays, manipulating methylation levels on targeted CpGs,<xref ref-type="bibr" rid="bib112"><sup>112</sup></xref> etc.) to directly test the biological role of methylation changes, other methods have been proposed. For example, this challenge can be overcome with a longitudinal experiment design, because epigenetic alterations that occur before or in the very early stage of the disease process are more likely to be related to disease etiology. In addition, some statistical approaches such as causal inference test (CIT)<xref ref-type="bibr" rid="bib45">45</xref>, <xref ref-type="bibr" rid="bib98">98</xref> and Mendelian randomization (MR)<xref ref-type="bibr" rid="bib113"><sup>113</sup></xref> have also been proposed and applied to investigate the causal role of epigenetic changes.<xref ref-type="bibr" rid="bib113">113</xref>, <xref ref-type="bibr" rid="bib114">114</xref>, <xref ref-type="bibr" rid="bib115">115</xref> Both approaches use genetic variants as an instrument to infer the causal effect of DNA methylation on the outcome. Because the mediation-based CIT test and MR approach use genetic instruments in different ways, each method has its own advantages as well as some disadvantages.<xref ref-type="bibr" rid="bib116"><sup>116</sup></xref></p>
</sec>
<sec id="sec6">
<title>Conflicts of interest</title>
<p id="p0095">The authors declare no conflicts of interest.</p>
</sec>
</body>
<back>
<ref-list id="cebib0010">
<title>References</title>
<ref id="bib1">
<label>1</label>
<element-citation id="sref1" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waddington</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>The epigenotype</article-title>
<source/>Endeavour
          <volume>1</volume>
<year>1942</year>
<fpage>18</fpage>
<lpage>20</lpage>
</element-citation>
</ref>
<ref id="bib2">
<label>2</label>
<element-citation id="sref2" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Waddington</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<chapter-title>The Strategy of the Genes: A Discussion of Some Aspects of Theoretical Biology. Ruskin House/Geo Ruskin House/George Allen and Unwin Ltd</chapter-title>
<year>1957</year>
<publisher-name>Londonrge Allen and Unwin Ltd.</publisher-name>
<publisher-loc>London</publisher-loc>
</element-citation>
</ref>
<ref id="bib3">
<label>3</label>
<element-citation id="sref3" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deichmann</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Epigenetics: the origins and evolution of a fashionable topic</article-title>
<source/>Dev Biol
          <volume>416</volume>
<issue>1</issue>
<year>2016</year>
<fpage>249</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="pmid">27291929</pub-id>
</element-citation>
</ref>
<ref id="bib4">
<label>4</label>
<element-citation id="sref4" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pujadas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Feinberg</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>Regulated noise in the epigenetic landscape of development and disease</article-title>
<source/>Cell
          <volume>148</volume>
<issue>6</issue>
<year>2012</year>
<fpage>1123</fpage>
<lpage>1131</lpage>
<pub-id pub-id-type="pmid">22424224</pub-id>
</element-citation>
</ref>
<ref id="bib5">
<label>5</label>
<element-citation id="sref5" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaenisch</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals</article-title>
<source/>Nat Genet
          <volume>33</volume>
<issue>suppl</issue>
<year>2003</year>
<fpage>245</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="pmid">12610534</pub-id>
</element-citation>
</ref>
<ref id="bib6">
<label>6</label>
<element-citation id="sref6" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moore</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>DNA methylation and its basic function</article-title>
<source/>Neuropsychopharmacology
          <volume>38</volume>
<issue>1</issue>
<year>2013</year>
<fpage>23</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="pmid">22781841</pub-id>
</element-citation>
</ref>
<ref id="bib7">
<label>7</label>
<element-citation id="sref7" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohli</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>TET enzymes, TDG and the dynamics of DNA demethylation</article-title>
<source/>Nature
          <volume>502</volume>
<issue>7472</issue>
<year>2013</year>
<fpage>472</fpage>
<lpage>479</lpage>
<pub-id pub-id-type="pmid">24153300</pub-id>
</element-citation>
</ref>
<ref id="bib8">
<label>8</label>
<element-citation id="sref8" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pastor</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Aravind</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>TETonic shift: biological roles of TET proteins in DNA demethylation and transcription</article-title>
<source/>Nat Rev Mol Cell Biol
          <volume>14</volume>
<issue>6</issue>
<year>2013</year>
<fpage>341</fpage>
<lpage>356</lpage>
<pub-id pub-id-type="pmid">23698584</pub-id>
</element-citation>
</ref>
<ref id="bib9">
<label>9</label>
<element-citation id="sref9" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Reversing DNA methylation: mechanisms, genomics, and biological functions</article-title>
<source/>Cell
          <volume>156</volume>
<issue>1-2</issue>
<year>2014</year>
<fpage>45</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">24439369</pub-id>
</element-citation>
</ref>
<ref id="bib10">
<label>10</label>
<element-citation id="sref10" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Isoform switch of TET1 regulates DNA demethylation and mouse development</article-title>
<source/>Mol Cell
          <volume>64</volume>
<issue>6</issue>
<year>2016</year>
<fpage>1062</fpage>
<lpage>1073</lpage>
<pub-id pub-id-type="pmid">27916660</pub-id>
</element-citation>
</ref>
<ref id="bib11">
<label>11</label>
<element-citation id="sref11" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The role of genomic imprinting in biology and disease: an expanding view</article-title>
<source/>Nat Rev Genet
          <volume>15</volume>
<issue>8</issue>
<year>2014</year>
<fpage>517</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="pmid">24958438</pub-id>
</element-citation>
</ref>
<ref id="bib12">
<label>12</label>
<element-citation id="sref12" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.-F.</given-names>
</name>
<name>
<surname>Ulaner</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites</article-title>
<source/>J Cell Biochem
          <volume>90</volume>
<issue>5</issue>
<year>2003</year>
<fpage>1038</fpage>
<lpage>1055</lpage>
<pub-id pub-id-type="pmid">14624463</pub-id>
</element-citation>
</ref>
<ref id="bib13">
<label>13</label>
<element-citation id="sref13" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cassidy</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Driscoll</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Prader-Willi syndrome</article-title>
<source/>Genet Med.
          <volume>14</volume>
<issue>1</issue>
<year>2012</year>
<fpage>10</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="pmid">22237428</pub-id>
</element-citation>
</ref>
<ref id="bib14">
<label>14</label>
<element-citation id="sref14" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Driscoll</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Dagli</surname>
<given-names>A.I.</given-names>
</name>
</person-group>
<article-title>Clinical and genetic aspects of Angelman syndrome</article-title>
<source/>Genet Med.
          <volume>12</volume>
<issue>7</issue>
<year>2010</year>
<fpage>385</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="pmid">20445456</pub-id>
</element-citation>
</ref>
<ref id="bib15">
<label>15</label>
<element-citation id="sref15" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCann</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>O'Meara</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Biallelic expression of the IGF2 gene in human breast disease</article-title>
<source/>Hum Mol Genet
          <volume>5</volume>
<issue>8</issue>
<year>1996</year>
<fpage>1123</fpage>
<lpage>1127</lpage>
<pub-id pub-id-type="pmid">8842730</pub-id>
</element-citation>
</ref>
<ref id="bib16">
<label>16</label>
<element-citation id="sref16" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Onyango</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brandenburg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>C.-L.</given-names>
</name>
<name>
<surname>Feinberg</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2</article-title>
<source/>Cancer Res
          <volume>62</volume>
<issue>22</issue>
<year>2002</year>
<fpage>6442</fpage>
<lpage>6446</lpage>
<pub-id pub-id-type="pmid">12438232</pub-id>
</element-citation>
</ref>
<ref id="bib17">
<label>17</label>
<element-citation id="sref17" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cruz-Correa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Giardiello</surname>
<given-names>F.M.</given-names>
</name>
</person-group>
<article-title>Loss of IGF2 imprinting: a potential marker of colorectal cancer risk</article-title>
<source/>Science
          <volume>299</volume>
<issue>5613</issue>
<year>2003</year>
<fpage>1753</fpage>
<lpage>1755</lpage>
<pub-id pub-id-type="pmid">12637750</pub-id>
</element-citation>
</ref>
<ref id="bib18">
<label>18</label>
<element-citation id="sref18" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulaner</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Vu</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site</article-title>
<source/>Hum Mol Genet
          <volume>12</volume>
<issue>5</issue>
<year>2003</year>
<fpage>535</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="pmid">12588801</pub-id>
</element-citation>
</ref>
<ref id="bib19">
<label>19</label>
<element-citation id="sref19" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer</article-title>
<source/>Mol Cancer Res
          <volume>4</volume>
<issue>4</issue>
<year>2006</year>
<fpage>283</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="pmid">16603642</pub-id>
</element-citation>
</ref>
<ref id="bib20">
<label>20</label>
<element-citation id="sref20" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byun</surname>
<given-names>H.-M.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>H.-L.</given-names>
</name>
<name>
<surname>Birnstein</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Wolff</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Examination of IGF2 and H19 loss of imprinting in bladder cancer</article-title>
<source/>Cancer Res
          <volume>67</volume>
<issue>22</issue>
<year>2007</year>
<fpage>10753</fpage>
<lpage>10758</lpage>
<pub-id pub-id-type="pmid">18006818</pub-id>
</element-citation>
</ref>
<ref id="bib21">
<label>21</label>
<element-citation id="sref21" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jelinic</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Loss of imprinting and cancer</article-title>
<source/>J Pathol
          <volume>211</volume>
<issue>3</issue>
<year>2007</year>
<fpage>261</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="pmid">17177177</pub-id>
</element-citation>
</ref>
<ref id="bib22">
<label>22</label>
<element-citation id="sref22" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>DeCoteau</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Geyer</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Casson</surname>
<given-names>A.G.</given-names>
</name>
</person-group>
<article-title>Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues</article-title>
<source/>Carcinogenesis
          <volume>30</volume>
<issue>12</issue>
<year>2009</year>
<fpage>2117</fpage>
<lpage>2122</lpage>
<pub-id pub-id-type="pmid">19843644</pub-id>
</element-citation>
</ref>
<ref id="bib23">
<label>23</label>
<element-citation id="sref23" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vu</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells</article-title>
<source/>Hum Mol Genet
          <volume>19</volume>
<issue>5</issue>
<year>2010</year>
<fpage>901</fpage>
<lpage>919</lpage>
<pub-id pub-id-type="pmid">20015958</pub-id>
</element-citation>
</ref>
<ref id="bib24">
<label>24</label>
<element-citation id="sref24" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhusari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kueck</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jarrard</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer</article-title>
<source/>Prostate
          <volume>71</volume>
<issue>15</issue>
<year>2011</year>
<fpage>1621</fpage>
<lpage>1630</lpage>
<pub-id pub-id-type="pmid">21432864</pub-id>
</element-citation>
</ref>
<ref id="bib25">
<label>25</label>
<element-citation id="sref25" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leick</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Shoff</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Congress</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Gallicano</surname>
<given-names>G.I.</given-names>
</name>
</person-group>
<article-title>Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer</article-title>
<source/>Am J Stem Cells
          <volume>1</volume>
<issue>1</issue>
<year>2012</year>
<fpage>59</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">23671798</pub-id>
</element-citation>
</ref>
<ref id="bib26">
<label>26</label>
<element-citation id="sref26" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feinberg</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Koldobskiy</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Göndör</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Epigenetic modulators, modifiers and mediators in cancer aetiology and progression</article-title>
<source/>Nat Rev Genet
          <volume>17</volume>
<issue>5</issue>
<year>2016</year>
<fpage>284</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="pmid">26972587</pub-id>
</element-citation>
</ref>
<ref id="bib27">
<label>27</label>
<element-citation id="sref27" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timp</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Feinberg</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host</article-title>
<source/>Nat Rev Cancer
          <volume>13</volume>
<issue>7</issue>
<year>2013</year>
<fpage>497</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="pmid">23760024</pub-id>
</element-citation>
</ref>
<ref id="bib28">
<label>28</label>
<element-citation id="sref28" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanahan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>The hallmarks of cancer</article-title>
<source/>Cell
          <volume>100</volume>
<issue>1</issue>
<year>2000</year>
<fpage>57</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">10647931</pub-id>
</element-citation>
</ref>
<ref id="bib29">
<label>29</label>
<element-citation id="sref29" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanahan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Hallmarks of cancer: the next generation</article-title>
<source/>Cell
          <volume>144</volume>
<issue>5</issue>
<year>2011</year>
<fpage>646</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="pmid">21376230</pub-id>
</element-citation>
</ref>
<ref id="bib30">
<label>30</label>
<element-citation id="sref30" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDonald</surname>
<given-names>O.G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis</article-title>
<source/>Nat Genet
          <volume>49</volume>
<issue>3</issue>
<year>2017</year>
<fpage>367</fpage>
<lpage>376</lpage>
<pub-id pub-id-type="pmid">28092686</pub-id>
</element-citation>
</ref>
<ref id="bib31">
<label>31</label>
<element-citation id="sref31" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makohon-Moore</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>J.G.</given-names>
</name>
</person-group>
<article-title>Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer</article-title>
<source/>Nat Genet
          <volume>49</volume>
<issue>3</issue>
<year>2017</year>
<fpage>358</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="pmid">28092682</pub-id>
</element-citation>
</ref>
<ref id="bib32">
<label>32</label>
<element-citation id="sref32" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Diep</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Plongthongkum</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fung</surname>
<given-names>H.-L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA</article-title>
<source/>Nat Genet
          <volume>49</volume>
<issue>4</issue>
<year>2017</year>
<fpage>635</fpage>
<lpage>642</lpage>
<pub-id pub-id-type="pmid">28263317</pub-id>
</element-citation>
</ref>
<ref id="bib33">
<label>33</label>
<element-citation id="sref33" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers</article-title>
<source/>Cell Res
          <volume>27</volume>
<issue>10</issue>
<year>2017</year>
<fpage>1243</fpage>
<lpage>1257</lpage>
<pub-id pub-id-type="pmid">28925386</pub-id>
</element-citation>
</ref>
<ref id="bib34">
<label>34</label>
<element-citation id="sref34" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>C.-X.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages</article-title>
<source/>Cell Res
          <volume>27</volume>
<issue>10</issue>
<year>2017</year>
<fpage>1231</fpage>
<lpage>1242</lpage>
<pub-id pub-id-type="pmid">28820176</pub-id>
</element-citation>
</ref>
<ref id="bib35">
<label>35</label>
<element-citation id="sref35" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lapinska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Faria</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>McGonagle</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Macumber</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Heerboth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cancer progenitor cells: the result of an epigenetic event?</article-title>
<source/>Anticancer Res
          <volume>38</volume>
<issue>1</issue>
<year>2018</year>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">29277749</pub-id>
</element-citation>
</ref>
<ref id="bib36">
<label>36</label>
<element-citation id="sref36" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Goldgar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Heerboth</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Genetic and epigenetic aspects of breast cancer progression and therapy</article-title>
<source/>Anticancer Res
          <volume>34</volume>
<issue>3</issue>
<year>2014</year>
<fpage>1071</fpage>
<lpage>1077</lpage>
<pub-id pub-id-type="pmid">24596345</pub-id>
</element-citation>
</ref>
<ref id="bib37">
<label>37</label>
<element-citation id="sref37" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Huh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>Y.-S.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Alteration of DNA methylation in gastric cancer with chemotherapy</article-title>
<source/>J Microbiol Biotechnol
          <volume>27</volume>
<issue>8</issue>
<year>2017</year>
<fpage>1367</fpage>
<lpage>1378</lpage>
<pub-id pub-id-type="pmid">28621113</pub-id>
</element-citation>
</ref>
<ref id="bib38">
<label>38</label>
<element-citation id="sref38" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aho</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Koskenvuo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tuominen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kaprio</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Occurrence of rheumatoid arthritis in a nationwide series of twins</article-title>
<source/>J Rheumatol
          <volume>13</volume>
<issue>5</issue>
<year>1986</year>
<fpage>899</fpage>
<lpage>902</lpage>
<pub-id pub-id-type="pmid">3820198</pub-id>
</element-citation>
</ref>
<ref id="bib39">
<label>39</label>
<element-citation id="sref39" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellamy</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Duffy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mathews</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Rheumatoid arthritis in twins: a study of aetiopathogenesis based on the Australian Twin Registry</article-title>
<source/>Ann Rheum Dis
          <volume>51</volume>
<issue>5</issue>
<year>1992</year>
<fpage>588</fpage>
<lpage>593</lpage>
<pub-id pub-id-type="pmid">1616321</pub-id>
</element-citation>
</ref>
<ref id="bib40">
<label>40</label>
<element-citation id="sref40" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deapen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Escalante</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weinrib</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>A revised estimate of twin concordance in systemic lupus erythematosus</article-title>
<source/>Arthritis Rheum
          <volume>35</volume>
<issue>3</issue>
<year>1992</year>
<fpage>311</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="pmid">1536669</pub-id>
</element-citation>
</ref>
<ref id="bib41">
<label>41</label>
<element-citation id="sref41" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Järvinen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Aho</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Twin studies in rheumatic diseases</article-title>
<source/>Semin Arthritis Rheum
          <volume>24</volume>
<issue>1</issue>
<year>1994</year>
<fpage>19</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="pmid">7985034</pub-id>
</element-citation>
</ref>
<ref id="bib42">
<label>42</label>
<element-citation id="sref42" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bammer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schaltenbrand</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Solcher</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Examinations of twins in multiple sclerosis</article-title>
<source/>Dtsch Z Nervenheilkd
          <volume>181</volume>
<year>1960</year>
<fpage>261</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="pmid">13686504</pub-id>
</element-citation>
</ref>
<ref id="bib43">
<label>43</label>
<element-citation id="sref43" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hutchinson</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Is male rheumatoid arthritis an occupational Disease? A review</article-title>
<source/>Open Rheumatol J
          <volume>11</volume>
<year>2017</year>
<fpage>88</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">28932330</pub-id>
</element-citation>
</ref>
<ref id="bib44">
<label>44</label>
<element-citation id="sref44" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majithia</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Geraci</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Rheumatoid arthritis: diagnosis and management</article-title>
<source/>Am J Med
          <volume>120</volume>
<issue>11</issue>
<year>2007</year>
<fpage>936</fpage>
<lpage>939</lpage>
<pub-id pub-id-type="pmid">17976416</pub-id>
</element-citation>
</ref>
<ref id="bib45">
<label>45</label>
<element-citation id="sref45" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aryee</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Padyukov</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis</article-title>
<source/>Nat Biotechnol
          <volume>31</volume>
<issue>2</issue>
<year>2013</year>
<fpage>142</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="pmid">23334450</pub-id>
</element-citation>
</ref>
<ref id="bib46">
<label>46</label>
<element-citation id="sref46" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Z.-H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>MeCP2 regulates PTCH1 expression through DNA methylation in rheumatoid arthritis</article-title>
<source/>Inflammation
          <volume>40</volume>
<issue>5</issue>
<year>2017</year>
<fpage>1497</fpage>
<lpage>1508</lpage>
<pub-id pub-id-type="pmid">28573530</pub-id>
</element-citation>
</ref>
<ref id="bib47">
<label>47</label>
<element-citation id="sref47" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glossop</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Nixon</surname>
<given-names>N.B.</given-names>
</name>
<name>
<surname>Emes</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>DNA methylation at diagnosis is associated with response to disease-modifying drugs in early rheumatoid arthritis</article-title>
<source/>Epigenomics
          <volume>9</volume>
<issue>4</issue>
<year>2017</year>
<fpage>419</fpage>
<lpage>428</lpage>
<pub-id pub-id-type="pmid">27885849</pub-id>
</element-citation>
</ref>
<ref id="bib48">
<label>48</label>
<element-citation id="sref48" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis</article-title>
<source/>Arthritis Res Ther
          <volume>19</volume>
<issue>1</issue>
<year>2017</year>
<fpage>71</fpage>
<pub-id pub-id-type="pmid">28356135</pub-id>
</element-citation>
</ref>
<ref id="bib49">
<label>49</label>
<element-citation id="sref49" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Nititham</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Elboudwarej</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Genome-wide assessment of differential DNA methylation associated with autoantibody production in systemic lupus erythematosus</article-title>
<source/>PLoS One
          <volume>10</volume>
<issue>7</issue>
<year>2015</year>
<fpage>e0129813</fpage>
<pub-id pub-id-type="pmid">26192630</pub-id>
</element-citation>
</ref>
<ref id="bib50">
<label>50</label>
<element-citation id="sref50" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>X.Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Effect of interleukin-6 promoter DNA methylation on the pathogenesis of systemic lupus erythematosus</article-title>
<source/>Zhonghua Yi Xue Za Zhi
          <volume>97</volume>
<issue>19</issue>
<year>2017</year>
<fpage>1491</fpage>
<lpage>1495</lpage>
<pub-id pub-id-type="pmid">28535641</pub-id>
</element-citation>
</ref>
<ref id="bib51">
<label>51</label>
<element-citation id="sref51" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sukapan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Promnarate</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Avihingsanon</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mutirangura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hirankarn</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Types of DNA methylation status of the interspersed repetitive sequences for LINE-1, Alu, HERV-E and HERV-K in the neutrophils from systemic lupus erythematosus patients and healthy controls</article-title>
<source/>J Hum Genet
          <volume>59</volume>
<issue>4</issue>
<year>2014</year>
<fpage>178</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="pmid">24430577</pub-id>
</element-citation>
</ref>
<ref id="bib52">
<label>52</label>
<element-citation id="sref52" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Compston</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Coles</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis</article-title>
<source/>Lancet (London, England)
          <volume>359</volume>
<issue>9313</issue>
<year>2002</year>
<fpage>1221</fpage>
<lpage>1231</lpage>
</element-citation>
</ref>
<ref id="bib53">
<label>53</label>
<element-citation id="sref53" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.-S.</given-names>
</name>
</person-group>
<article-title>DNA methylation: a new player in multiple sclerosis</article-title>
<source/>Mol Neurobiol
          <volume>54</volume>
<issue>6</issue>
<year>2017</year>
<fpage>4049</fpage>
<lpage>4059</lpage>
<pub-id pub-id-type="pmid">27314687</pub-id>
</element-citation>
</ref>
<ref id="bib54">
<label>54</label>
<element-citation id="sref54" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chomyk</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Volsko</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>DNA methylation in demyelinated multiple sclerosis hippocampus</article-title>
<source/>Sci Rep
          <volume>7</volume>
<issue>1</issue>
<year>2017</year>
<fpage>8696</fpage>
<pub-id pub-id-type="pmid">28821749</pub-id>
</element-citation>
</ref>
<ref id="bib55">
<label>55</label>
<element-citation id="sref55" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marabita</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Almgren</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sjöholm</surname>
<given-names>L.K.</given-names>
</name>
</person-group>
<article-title>Smoking induces DNA methylation changes in multiple sclerosis patients with exposure-response relationship</article-title>
<source/>Sci Rep
          <volume>7</volume>
<issue>1</issue>
<year>2017</year>
<fpage>14589</fpage>
<pub-id pub-id-type="pmid">29109506</pub-id>
</element-citation>
</ref>
<ref id="bib56">
<label>56</label>
<element-citation id="sref56" publication-type="journal">
<person-group person-group-type="author">
<collab>GBD 2015 Disease and Injury Incidence and Prevalence Collaborators</collab>
</person-group>
<article-title>Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015</article-title>
<source/>Lancet (London, England)
          <volume>388</volume>
<issue>10053</issue>
<year>2016</year>
<fpage>1545</fpage>
<lpage>1602</lpage>
</element-citation>
</ref>
<ref id="bib57">
<label>57</label>
<element-citation id="sref57" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dayeh</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Volkov</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Salö</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion</article-title>
<source/>PLoS Genet
          <volume>10</volume>
<issue>3</issue>
<year>2014</year>
<fpage>e1004160</fpage>
<pub-id pub-id-type="pmid">24603685</pub-id>
</element-citation>
</ref>
<ref id="bib58">
<label>58</label>
<element-citation id="sref58" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>The shortening of leukocyte telomere length relates to DNA hypermethylation of LINE-1 in type 2 diabetes mellitus</article-title>
<source/>Oncotarget
          <volume>8</volume>
<issue>43</issue>
<year>2017</year>
<fpage>73964</fpage>
<lpage>73973</lpage>
<pub-id pub-id-type="pmid">29088760</pub-id>
</element-citation>
</ref>
<ref id="bib59">
<label>59</label>
<element-citation id="sref59" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soriano-Tárraga</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiménez-Conde</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Giralt-Steinhauer</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia</article-title>
<source/>Hum Mol Genet
          <volume>25</volume>
<issue>3</issue>
<year>2016</year>
<fpage>609</fpage>
<lpage>619</lpage>
<pub-id pub-id-type="pmid">26643952</pub-id>
</element-citation>
</ref>
<ref id="bib60">
<label>60</label>
<element-citation id="sref60" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dick</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Tsaprouni</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>DNA methylation and body-mass index: a genome-wide analysis</article-title>
<source/>Lancet (London, England)
          <volume>383</volume>
<issue>9933</issue>
<year>2014</year>
<fpage>1990</fpage>
<lpage>1998</lpage>
</element-citation>
</ref>
<ref id="bib61">
<label>61</label>
<element-citation id="sref61" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burris</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Baccarelli</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Byun</surname>
<given-names>H.-M.</given-names>
</name>
</person-group>
<article-title>Offspring DNA methylation of the aryl-hydrocarbon receptor repressor gene is associated with maternal BMI, gestational age, and birth weight</article-title>
<source/>Epigenetics
          <volume>10</volume>
<issue>10</issue>
<year>2015</year>
<fpage>913</fpage>
<lpage>921</lpage>
<pub-id pub-id-type="pmid">26252179</pub-id>
</element-citation>
</ref>
<ref id="bib62">
<label>62</label>
<element-citation id="sref62" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houde</surname>
<given-names>A.-A.</given-names>
</name>
<name>
<surname>Légaré</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Biron</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI, waist girth and LDL-cholesterol levels in severely obese men and women</article-title>
<source/>BMC Med Genet
          <volume>16</volume>
<year>2015</year>
<fpage>29</fpage>
<pub-id pub-id-type="pmid">25929254</pub-id>
</element-citation>
</ref>
<ref id="bib63">
<label>63</label>
<element-citation id="sref63" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Toro-Martín</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guénard</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tchernof</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A CpG-SNP located within the ARPC3 gene promoter is associated with hypertriglyceridemia in severely obese patients</article-title>
<source/>Ann Nutr Metab
          <volume>68</volume>
<issue>3</issue>
<year>2016</year>
<fpage>203</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="pmid">27055012</pub-id>
</element-citation>
</ref>
<ref id="bib64">
<label>64</label>
<element-citation id="sref64" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guay</surname>
<given-names>S.-P.</given-names>
</name>
<name>
<surname>Voisin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brisson</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration</article-title>
<source/>Epigenomics
          <volume>4</volume>
<issue>6</issue>
<year>2012</year>
<fpage>623</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="pmid">23244308</pub-id>
</element-citation>
</ref>
<ref id="bib65">
<label>65</label>
<element-citation id="sref65" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guay</surname>
<given-names>S.-P.</given-names>
</name>
<name>
<surname>Légaré</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brisson</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Epigenetic and genetic variations at the TNNT1 gene locus are associated with HDL-C levels and coronary artery disease</article-title>
<source/>Epigenomics
          <volume>8</volume>
<issue>3</issue>
<year>2016</year>
<fpage>359</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="pmid">26950807</pub-id>
</element-citation>
</ref>
<ref id="bib66">
<label>66</label>
<element-citation id="sref66" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braun</surname>
<given-names>K.V.E.</given-names>
</name>
<name>
<surname>Dhana</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>P.S.</given-names>
</name>
</person-group>
<article-title>Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study</article-title>
<source/>Clin Epigenet
          <volume>9</volume>
<year>2017</year>
<fpage>15</fpage>
</element-citation>
</ref>
<ref id="bib67">
<label>67</label>
<element-citation id="sref67" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verloigne</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Loyen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Van Hecke</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Variation in population levels of sedentary time in European children and adolescents according to cross-European studies: a systematic literature review within DEDIPAC</article-title>
<source/>Int J Behav Nutr Phys Act
          <volume>13</volume>
<year>2016</year>
<fpage>69</fpage>
<pub-id pub-id-type="pmid">27350043</pub-id>
</element-citation>
</ref>
<ref id="bib68">
<label>68</label>
<element-citation id="sref68" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>O'Roak</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>
<source/>Nature
          <volume>515</volume>
<issue>7526</issue>
<year>2014</year>
<fpage>216</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">25363768</pub-id>
</element-citation>
</ref>
<ref id="bib69">
<label>69</label>
<element-citation id="sref69" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>I.B.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>C.Q.</given-names>
</name>
<name>
<surname>Francke</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>
<source/>Nat Genet
          <volume>23</volume>
<issue>2</issue>
<year>1999</year>
<fpage>185</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="pmid">10508514</pub-id>
</element-citation>
</ref>
<ref id="bib70">
<label>70</label>
<element-citation id="sref70" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuddapah</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Pillai</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Shekar</surname>
<given-names>K.V.</given-names>
</name>
</person-group>
<article-title>Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome</article-title>
<source/>J Med Genet
          <volume>51</volume>
<issue>3</issue>
<year>2014</year>
<fpage>152</fpage>
<lpage>158</lpage>
<pub-id pub-id-type="pmid">24399845</pub-id>
</element-citation>
</ref>
<ref id="bib71">
<label>71</label>
<element-citation id="sref71" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lavery</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome</article-title>
<source/>Proc Natl Acad Sci U S A
          <volume>112</volume>
<issue>17</issue>
<year>2015</year>
<fpage>5509</fpage>
<lpage>5514</lpage>
<pub-id pub-id-type="pmid">25870282</pub-id>
</element-citation>
</ref>
<ref id="bib72">
<label>72</label>
<element-citation id="sref72" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correction for Chen et al</surname>
</name>
</person-group>
<article-title>MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome</article-title>
<source/>Proc Natl Acad Sci U S A
          <volume>112</volume>
<issue>22</issue>
<year>2015</year>
<fpage>E2982</fpage>
<pub-id pub-id-type="pmid">25918409</pub-id>
</element-citation>
</ref>
<ref id="bib73">
<label>73</label>
<element-citation id="sref73" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fasolino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>The Crucial Role of DNA Methylation and MeCP2 in Neuronal Function</article-title>
<source/>Genes (Basel)
          <issue>5</issue>
<year>2017</year>
<fpage>8</fpage>
</element-citation>
</ref>
<ref id="bib74">
<label>74</label>
<element-citation id="sref74" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.-T.</given-names>
</name>
</person-group>
<article-title>Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2</article-title>
<source/>Nature
          <volume>530</volume>
<issue>7588</issue>
<year>2016</year>
<fpage>98</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="pmid">26808898</pub-id>
</element-citation>
</ref>
<ref id="bib75">
<label>75</label>
<element-citation id="sref75" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>X.-R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.-S.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>MeCP2 deficiency in neuroglia: new progress in the pathogenesis of Rett syndrome</article-title>
<source/>Front Mol Neurosci
          <volume>10</volume>
<year>2017</year>
<fpage>316</fpage>
<pub-id pub-id-type="pmid">29046627</pub-id>
</element-citation>
</ref>
<ref id="bib76">
<label>76</label>
<element-citation id="sref76" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>D.I.</given-names>
</name>
<name>
<surname>Crary-Dooley</surname>
<given-names>F.K.</given-names>
</name>
</person-group>
<article-title>Self-reported pregnancy exposures and placental DNA methylation in the MARBLES prospective autism sibling study</article-title>
<source/>Environ Epigenetics
          <volume>4</volume>
<issue>2</issue>
<year>2016</year>
</element-citation>
</ref>
<ref id="bib77">
<label>77</label>
<element-citation id="sref77" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nardone</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sams</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Zito</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Reuveni</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Dysregulation of cortical neuron DNA methylation profile in autism spectrum disorder</article-title>
<source/>Cereb Cortex
          <volume>27</volume>
<issue>12</issue>
<year>2017</year>
<fpage>5739</fpage>
<lpage>5754</lpage>
<pub-id pub-id-type="pmid">29028941</pub-id>
</element-citation>
</ref>
<ref id="bib78">
<label>78</label>
<element-citation id="sref78" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrews</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Bakulski</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Cross-tissue integration of genetic and epigenetic data offers insight into autism spectrum disorder</article-title>
<source/>Nat Commun
          <volume>8</volume>
<issue>1</issue>
<year>2017</year>
<fpage>1011</fpage>
<pub-id pub-id-type="pmid">29066808</pub-id>
</element-citation>
</ref>
<ref id="bib79">
<label>79</label>
<element-citation id="sref79" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nour El Huda</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Norsidah</surname>
<given-names>K.Z.</given-names>
</name>
<name>
<surname>Mohd Nabil Fikri</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hanisah</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Kartini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Norlelawati</surname>
<given-names>A.T.</given-names>
</name>
</person-group>
<article-title>DNA methylation of MB-COMT in Malaysian schizophrenia patients</article-title>
<source/>Psychiatry Clin Neurosci
          <year>November 2017</year>
</element-citation>
</ref>
<ref id="bib80">
<label>80</label>
<element-citation id="sref80" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shorter</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>B.H.</given-names>
</name>
</person-group>
<article-title>Epigenetic mechanisms in schizophrenia</article-title>
<source/>Prog Biophys Mol Biol
          <volume>118</volume>
<issue>1-2</issue>
<year>2015</year>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">25958205</pub-id>
</element-citation>
</ref>
<ref id="bib81">
<label>81</label>
<element-citation id="sref81" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ovenden</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>McGregor</surname>
<given-names>N.W.</given-names>
</name>
<name>
<surname>Emsley</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Warnich</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>DNA methylation and antipsychotic treatment mechanisms in schizophrenia: progress and future directions</article-title>
<source/>Prog Neuro-Psychopharmacol Biol Psychiatry
          <volume>81</volume>
<year>2018</year>
<fpage>38</fpage>
<lpage>49</lpage>
</element-citation>
</ref>
<ref id="bib82">
<label>82</label>
<element-citation id="sref82" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dashtipour</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tafreshi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Adler</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Hypermethylation of Synphilin-1, alpha-synuclein-interacting protein (SNCAIP) gene in the cerebral cortex of patients with sporadic Parkinson's disease</article-title>
<source/>Brain Sci
          <issue>7</issue>
<year>2017</year>
<fpage>7</fpage>
</element-citation>
</ref>
<ref id="bib83">
<label>83</label>
<element-citation id="sref83" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chuang</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Bronstein</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Bordelon</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ritz</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Parkinson's disease is associated with DNA methylation levels in human blood and saliva</article-title>
<source/>Genome Med
          <volume>9</volume>
<issue>1</issue>
<year>2017</year>
<fpage>76</fpage>
<pub-id pub-id-type="pmid">28851441</pub-id>
</element-citation>
</ref>
<ref id="bib84">
<label>84</label>
<element-citation id="sref84" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eryilmaz</surname>
<given-names>I.E.</given-names>
</name>
<name>
<surname>Cecener</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Erer</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions</article-title>
<source/>Neurol Res
          <volume>39</volume>
<issue>11</issue>
<year>2017</year>
<fpage>965</fpage>
<lpage>972</lpage>
<pub-id pub-id-type="pmid">28830306</pub-id>
</element-citation>
</ref>
<ref id="bib85">
<label>85</label>
<element-citation id="sref85" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bulterijs</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hull</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Björk</surname>
<given-names>V.C.E.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>A.G.</given-names>
</name>
</person-group>
<article-title>It is time to classify biological aging as a disease</article-title>
<source/>Front Genet
          <volume>6</volume>
<year>2015</year>
<fpage>205</fpage>
<pub-id pub-id-type="pmid">26150825</pub-id>
</element-citation>
</ref>
<ref id="bib86">
<label>86</label>
<element-citation id="sref86" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berdyshev</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Korotaev</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Boiarskikh</surname>
<given-names>G.V.</given-names>
</name>
<name>
<surname>Vaniushin</surname>
<given-names>B.F.</given-names>
</name>
</person-group>
<article-title>Nucleotide composition of DNA and RNA from somatic tissues of humpback and its changes during spawning</article-title>
<source/>Biokhimiia
          <volume>32</volume>
<issue>5</issue>
<year>1967</year>
<fpage>988</fpage>
<lpage>993</lpage>
<pub-id pub-id-type="pmid">5628601</pub-id>
</element-citation>
</ref>
<ref id="bib87">
<label>87</label>
<element-citation id="sref87" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanyushin</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Nemirovsky</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Klimenko</surname>
<given-names>V.V.</given-names>
</name>
<name>
<surname>Vasiliev</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Belozersky</surname>
<given-names>A.N.</given-names>
</name>
</person-group>
<article-title>The 5-methylcytosine in DNA of rats. Tissue and age specificity and the changes induced by hydrocortisone and other agents</article-title>
<source/>Gerontologia
          <volume>19</volume>
<issue>3</issue>
<year>1973</year>
<fpage>138</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="pmid">4763637</pub-id>
</element-citation>
</ref>
<ref id="bib88">
<label>88</label>
<element-citation id="sref88" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>R.G.</given-names>
</name>
</person-group>
<article-title>Genomic 5-methyldeoxycytidine decreases with age</article-title>
<source/>J Biol Chem
          <volume>262</volume>
<issue>21</issue>
<year>1987</year>
<fpage>9948</fpage>
<lpage>9951</lpage>
<pub-id pub-id-type="pmid">3611071</pub-id>
</element-citation>
</ref>
<ref id="bib89">
<label>89</label>
<element-citation id="sref89" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>DNA methylation age of human tissues and cell types</article-title>
<source/>Genome Biol
          <volume>14</volume>
<issue>10</issue>
<year>2013</year>
<fpage>R115</fpage>
<pub-id pub-id-type="pmid">24138928</pub-id>
</element-citation>
</ref>
<ref id="bib90">
<label>90</label>
<element-citation id="sref90" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Erratum to: DNA methylation age of human tissues and cell types</article-title>
<source/>Genome Biol
          <volume>16</volume>
<year>2015</year>
<fpage>96</fpage>
<pub-id pub-id-type="pmid">25968125</pub-id>
</element-citation>
</ref>
<ref id="bib91">
<label>91</label>
<element-citation id="sref91" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ritz</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients</article-title>
<source/>Aging (Albany NY)
          <volume>7</volume>
<issue>12</issue>
<year>2015</year>
<fpage>1130</fpage>
<lpage>1142</lpage>
<pub-id pub-id-type="pmid">26655927</pub-id>
</element-citation>
</ref>
<ref id="bib92">
<label>92</label>
<element-citation id="sref92" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Langfelder</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kwak</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels</article-title>
<source/>Aging (Albany NY)
          <volume>8</volume>
<issue>7</issue>
<year>2016</year>
<fpage>1485</fpage>
<lpage>1512</lpage>
<pub-id pub-id-type="pmid">27479945</pub-id>
</element-citation>
</ref>
<ref id="bib93">
<label>93</label>
<element-citation id="sref93" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levine</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning</article-title>
<source/>Aging (Albany NY)
          <volume>7</volume>
<issue>12</issue>
<year>2015</year>
<fpage>1198</fpage>
<lpage>1211</lpage>
<pub-id pub-id-type="pmid">26684672</pub-id>
</element-citation>
</ref>
<ref id="bib94">
<label>94</label>
<element-citation id="sref94" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>HIV-1 infection accelerates age according to the epigenetic clock</article-title>
<source/>J Infect Dis
          <volume>212</volume>
<issue>10</issue>
<year>2015</year>
<fpage>1563</fpage>
<lpage>1573</lpage>
<pub-id pub-id-type="pmid">25969563</pub-id>
</element-citation>
</ref>
<ref id="bib95">
<label>95</label>
<element-citation id="sref95" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakulski</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Fallin</surname>
<given-names>M.D.</given-names>
</name>
</person-group>
<article-title>Epigenetic epidemiology: promises for public health research</article-title>
<source/>Environ Mol Mutagen
          <volume>55</volume>
<issue>3</issue>
<year>2014</year>
<fpage>171</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="pmid">24449392</pub-id>
</element-citation>
</ref>
<ref id="bib96">
<label>96</label>
<element-citation id="sref96" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lunnon</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schalkwyk</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mill</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes</article-title>
<source/>Epigenetics
          <volume>10</volume>
<issue>11</issue>
<year>2015</year>
<fpage>1024</fpage>
<lpage>1032</lpage>
<pub-id pub-id-type="pmid">26457534</pub-id>
</element-citation>
</ref>
<ref id="bib97">
<label>97</label>
<element-citation id="sref97" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farré</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Meaney</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Emberly</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kobor</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Concordant and discordant DNA methylation signatures of aging in human blood and brain</article-title>
<source/>Epigenet Chromatin
          <volume>8</volume>
<year>2015</year>
<fpage>19</fpage>
</element-citation>
</ref>
<ref id="bib98">
<label>98</label>
<element-citation id="sref98" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ladd-Acosta</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children</article-title>
<source/>Nat Commun
          <volume>6</volume>
<year>2015</year>
<fpage>6304</fpage>
<pub-id pub-id-type="pmid">25710614</pub-id>
</element-citation>
</ref>
<ref id="bib99">
<label>99</label>
<element-citation id="sref99" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joubert</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Felix</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Yousefi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis</article-title>
<source/>Am J Hum Genet
          <volume>98</volume>
<issue>4</issue>
<year>2016</year>
<fpage>680</fpage>
<lpage>696</lpage>
<pub-id pub-id-type="pmid">27040690</pub-id>
</element-citation>
</ref>
<ref id="bib100">
<label>100</label>
<element-citation id="sref100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardenas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Allard</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Doyon</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Validation of a DNA methylation reference panel for the estimation of nucleated cells types in cord blood</article-title>
<source/>Epigenetics
          <volume>11</volume>
<issue>11</issue>
<year>2016</year>
<fpage>773</fpage>
<lpage>779</lpage>
<pub-id pub-id-type="pmid">27668573</pub-id>
</element-citation>
</ref>
<ref id="bib101">
<label>101</label>
<element-citation id="sref101" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakulski</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Feinberg</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>S.V.</given-names>
</name>
</person-group>
<article-title>DNA methylation of cord blood cell types: applications for mixed cell birth studies</article-title>
<source/>Epigenetics
          <volume>11</volume>
<issue>5</issue>
<year>2016</year>
<fpage>354</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="pmid">27019159</pub-id>
</element-citation>
</ref>
<ref id="bib102">
<label>102</label>
<element-citation id="sref102" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guintivano</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Aryee</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Kaminsky</surname>
<given-names>Z.A.</given-names>
</name>
</person-group>
<article-title>A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression</article-title>
<source/>Epigenetics
          <volume>8</volume>
<issue>3</issue>
<year>2013</year>
<fpage>290</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="pmid">23426267</pub-id>
</element-citation>
</ref>
<ref id="bib103">
<label>103</label>
<element-citation id="sref103" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lippert</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Heckerman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Aryee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Listgarten</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Epigenome-wide association studies without the need for cell-type composition</article-title>
<source/>Nat Methods
          <volume>11</volume>
<issue>3</issue>
<year>2014</year>
<fpage>309</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="pmid">24464286</pub-id>
</element-citation>
</ref>
<ref id="bib104">
<label>104</label>
<element-citation id="sref104" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahmani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zaitlen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Baran</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Sparse PCA corrects for cell type heterogeneity in epigenome-wide association studies</article-title>
<source/>Nat Methods
          <volume>13</volume>
<issue>5</issue>
<year>2016</year>
<fpage>443</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="pmid">27018579</pub-id>
</element-citation>
</ref>
<ref id="bib105">
<label>105</label>
<element-citation id="sref105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houseman</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Molitor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Marsit</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Reference-free cell mixture adjustments in analysis of DNA methylation data</article-title>
<source/>Bioinformatics
          <volume>30</volume>
<issue>10</issue>
<year>2014</year>
<fpage>1431</fpage>
<lpage>1439</lpage>
<pub-id pub-id-type="pmid">24451622</pub-id>
</element-citation>
</ref>
<ref id="bib106">
<label>106</label>
<element-citation id="sref106" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maksimovic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gagnon-Bartsch</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Speed</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Oshlack</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Removing unwanted variation in a differential methylation analysis of Illumina HumanMethylation450 array data</article-title>
<source/>Nucleic Acids Res
          <volume>43</volume>
<issue>16</issue>
<year>2015</year>
<fpage>e106</fpage>
<pub-id pub-id-type="pmid">25990733</pub-id>
</element-citation>
</ref>
<ref id="bib107">
<label>107</label>
<element-citation id="sref107" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leek</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Storey</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Capturing heterogeneity in gene expression studies by surrogate variable analysis</article-title>
<source/>PLoS Genet
          <volume>3</volume>
<issue>9</issue>
<year>2007</year>
<fpage>1724</fpage>
<lpage>1735</lpage>
<pub-id pub-id-type="pmid">17907809</pub-id>
</element-citation>
</ref>
<ref id="bib108">
<label>108</label>
<element-citation id="sref108" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teschendorff</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Widschwendter</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies</article-title>
<source/>Bioinformatics
          <volume>27</volume>
<issue>11</issue>
<year>2011</year>
<fpage>1496</fpage>
<lpage>1505</lpage>
<pub-id pub-id-type="pmid">21471010</pub-id>
</element-citation>
</ref>
<ref id="bib109">
<label>109</label>
<element-citation id="sref109" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teschendorff</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Cell-type deconvolution in epigenome-wide association studies: a review and recommendations</article-title>
<source/>Epigenomics
          <volume>9</volume>
<issue>5</issue>
<year>2017</year>
<fpage>757</fpage>
<lpage>768</lpage>
<pub-id pub-id-type="pmid">28517979</pub-id>
</element-citation>
</ref>
<ref id="bib110">
<label>110</label>
<element-citation id="sref110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pogribny</surname>
<given-names>I.P.</given-names>
</name>
<name>
<surname>Rusyn</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Environmental toxicants, epigenetics, and cancer</article-title>
<source/>Adv Exp Med Biol
          <volume>754</volume>
<year>2013</year>
<fpage>215</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="pmid">22956504</pub-id>
</element-citation>
</ref>
<ref id="bib111">
<label>111</label>
<element-citation id="sref111" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrès</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Egan</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Acute exercise remodels promoter methylation in human skeletal muscle</article-title>
<source/>Cell Metab
          <volume>15</volume>
<issue>3</issue>
<year>2012</year>
<fpage>405</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="pmid">22405075</pub-id>
</element-citation>
</ref>
<ref id="bib112">
<label>112</label>
<element-citation id="sref112" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pulecio</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mejía-Ramírez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Huangfu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Raya</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>CRISPR/Cas9-Based engineering of the epigenome</article-title>
<source/>Cell Stem Cell
          <volume>21</volume>
<issue>4</issue>
<year>2017</year>
<fpage>431</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="pmid">28985525</pub-id>
</element-citation>
</ref>
<ref id="bib113">
<label>113</label>
<element-citation id="sref113" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tilling</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Davey Smith</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Orienting the causal relationship between imprecisely measured traits using GWAS summary data</article-title>
<source/>PLoS Genet
          <volume>13</volume>
<issue>11</issue>
<year>2017</year>
<fpage>e1007081</fpage>
<pub-id pub-id-type="pmid">29149188</pub-id>
</element-citation>
</ref>
<ref id="bib114">
<label>114</label>
<element-citation id="sref114" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dekkers</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>van Iterson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Slieker</surname>
<given-names>R.C.</given-names>
</name>
</person-group>
<article-title>Blood lipids influence DNA methylation in circulating cells</article-title>
<source/>Genome Biol
          <volume>17</volume>
<issue>1</issue>
<year>2016</year>
<fpage>138</fpage>
<pub-id pub-id-type="pmid">27350042</pub-id>
</element-citation>
</ref>
<ref id="bib115">
<label>115</label>
<element-citation id="sref115" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morales</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vilahur</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Salas</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Genome-wide DNA methylation study in human placenta identifies novel loci associated with maternal smoking during pregnancy</article-title>
<source/>Int J Epidemiol
          <volume>45</volume>
<issue>5</issue>
<year>2016</year>
<fpage>1644</fpage>
<lpage>1655</lpage>
<pub-id pub-id-type="pmid">27591263</pub-id>
</element-citation>
</ref>
<ref id="bib116">
<label>116</label>
<element-citation id="sref116" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teschendorff</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Relton</surname>
<given-names>C.L.</given-names>
</name>
</person-group>
<article-title>Statistical and integrative system-level analysis of DNA methylation data</article-title>
<source/>Nat Rev Genet
          <volume>19</volume>
<issue>3</issue>
<year>2018</year>
<fpage>129</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="pmid">29129922</pub-id>
</element-citation>
</ref>
</ref-list>
<ack id="ack0010">
<title>Acknowledgement</title>
<p>This work was supported by from <funding-source id="gs1">National Basic Research Program of China (973 program)</funding-source> (No. 2015CB910401 to Yun Liu) and the <funding-source id="gs2">National Natural Science Foundation of China</funding-source> (No. 31471212 and No. 31771451 to Yun Liu).</p>
</ack>
<fn-group>
<fn id="d31e22">
<p id="ntpara0010">Peer review under responsibility of Chongqing Medical University.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>